Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Endometrial Cancer Treatment
... at a CAGR of 5.0% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$31.3 Billion by the end of the ... Read More
-
Benign Prostatic Hyperplasia (BPH) Drugs
... Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Alpha-Blockers, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.4 Billion by ... Read More
-
Brain Implants
... CAGR of 10.6% over the analysis period 2024-2030. Deep Brain Stimulation, one of the segments analyzed in the report, is expected to record a 11.2% CAGR and reach US$8.7 Billion by the end of the ... Read More
-
Gastroparesis Drugs
... CAGR of 4.8% over the analysis period 2024-2030. Idiopathic Gastroparesis Drugs, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Adult Stores
... CAGR of 6.8% over the analysis period 2024-2030. Sex Toys, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$34.6 Billion by the end of the analysis ... Read More
-
Antipsychotic Drugs
... CAGR of 6.8% over the analysis period 2024-2030. Second Generation Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$15.7 Billion by the end of ... Read More
-
Artificial Insemination
... CAGR of 7.2% over the analysis period 2024-2030. Intrauterine Insemination, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$2.8 Billion by the end of the analysis ... Read More
-
Bone Cement and Glue
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Bone Cement, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.1 Billion by the ... Read More
-
Brain Health Supplements
... at a CAGR of 5.4% over the analysis period 2024-2030. Natural Molecules, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$6.8 Billion by the end of ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
NDDS in Cancer Therapy
... 2030, growing at a CAGR of 20.7% over the analysis period 2024-2030. Nanoparticles, one of the segments analyzed in the report, is expected to record a 20.6% CAGR and reach US$67.8 Billion by the end ... Read More
-
Brain Computer Interface
... at a CAGR of 10.3% over the analysis period 2024-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Constipation Treatment
... CAGR of 5.9% over the analysis period 2024-2030. Laxatives, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.3 Billion by the end of the analysis period. ... Read More
-
Glioblastoma Multiforme Treatment (GBM)
... 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Radiation Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the ... Read More
-
Hyperpigmentation Disorders Treatment
... at a CAGR of 5.9% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.3 Billion by the end of ... Read More
-
Ligament Stabilizers
... CAGR of 4.6% over the analysis period 2024-2030. Grade 1 Injury, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.0 Billion by the end of the ... Read More
-
Orthopedic Digit Implants
... at a CAGR of 5.3% over the analysis period 2024-2030. Metatarsal Joint Implants, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$202.2 Million by the end ... Read More
-
Periodontal Therapeutics
... CAGR of 8.6% over the analysis period 2024-2030. Systemic Antibiotics, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$623.3 Million by the end of the analysis ... Read More
-
Small Bone and Joint Orthopedic Devices
... reach US$20.4 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Fracture Fixation & Replacement Systems, one of the segments analyzed in the report, is expected to record a 7.7% ... Read More
-
Brachytherapy
... 4.3% over the analysis period 2024-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis ... Read More
-
Ocular Prosthesis
... CAGR of 6.6% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion by the end of the analysis ... Read More
-
Foot and Ankle Braces
... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. The U.S. Market is Estimated at US$256.8 Million While China is Forecast to Grow at 10.6% CAGR The Foot and Ankle Braces market ... Read More
-
Wrist and Hand Braces
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$90.5 Million While China is Forecast to Grow at 9.6% CAGR The Wrist and Hand Braces market ... Read More
-
Metabolic Disorder Therapeutics
... at a CAGR of 6.9% over the analysis period 2024-2030. Diabetes Therapeutics, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$91.9 Billion by the end of ... Read More
-
Non-Small Cell Lung Cancer (NSCLC) Therapeutics
... reach US$54.0 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach ... Read More
Research Assistance
